the highest titers and were chosen for further study. All were of the IgG 1 isotype. To determine the epitopes recognized by these mAbs, homogeneous synthetic peptides covering the whole TGF-a molecule were used (Fig. 1 ). TGF-a is a tricyclic protein with three disulfide loops. Loops A and B form a fused ring whereas loop C forms an independent disulfide ring . Loop C represents the segment with the strongest homology with EGF, with 6 of 10 residues being conserved (Cysx2GlyTyrxGlyxArgCys; where x represents other amino acids) . In contrast, loop B represents the segment with the least homology with EGF, with only 4 of 17 residues being conserved (Cysx2GlyxCysx,ocys) (1). In a sensitive ELISA, mAb A1 .5 bound to loop B but not loops A or C even at peptide concentrations of 0.1 mg/ml (Fig. 2) .
TGF-a is expressed by normal and malignant keratinocytes. Formalin-fixed frozen skin sections were tested for reactivity with mAb A1 .5 using the immunoperoxidase technique (Fig. 3) . Keratinocytes in eight nodular basal cell carcinomas (a and b), one morpheic basal cell carcinoma (d), and one squamous cell carcinoma (e) demonstrated intense staining with mAb A1 .5. Of even greater interest was the observation that the overlying normal epidermis (c), as well as the epidermis from five normal skin specimens, were stained by the mAb. The pattern of staining was membranous . Keratinocytes in the epidermal appendages, which are developmentally derived from basal keratinocytes, were also reactive with mAb Al .5 . mAb A9.10 showed an identical staining pattern, as did mAb A1 .5. mAb B6.1 as well as an isotype control were nonreactive with both normal and malignant keratinocytes. Keratinocytes in plaques from 18 psoriasis patients were reactive with mAb A1 .5 (Fig. 3f) . In general, they were more intensely stained than those from normal skin. Cultured normal keratinocytes isolated from breast skin were trypsinized and then cytocentrifuged onto glass slides . Clear membrane staining with the anti-TGF-a antibody was observed (Fig. 3g) .
In the mononuclear dermal infiltrates of both psoriasis and basal cell carcinoma specimens there was clear reactivity with mAb Al .5 (Fig. 3 h) . We have previously demonstrated that these infiltrates contained activated T cells, macrophages, and Langerhans' cells (6) . In the psoriatic plaques, endothelial cells also appeared to be stained. The exact identity of the cell(s) reacting with the anti-TGF-a antibody is still under active investigation.
To confirm that the reactivity of normal and malignant keratinocytes with the anti-TGF-a antibodies was specific, competition experiments were performed. Synthetic human TGF-a, at a concentration of 2,ug/ml, was added to mAb Al .5 immediately before the mixture was incubated with basal cell carcinoma and normal skin sections . TGF-a completely removed the reactivity of mAb A1 .5 with both the basal cell tumor and normal epidermis (Fig. 4) . EGF at similar concentrations did not compete in binding to mAb A 1 .5 .
Discussion TGF-a was demonstrated on the membrane of normal, hyperproliferative, and malignant keratinocytes . Its presence in normal keratinocytes strongly suggests that it plays an important role in the normal physiological control of keratinocyte proliferation . Inhibition of TGF-a-induced transformation may be effected by local cellular and humoral elements as has been described for the viral myc and ras oncogenes (8) .
The presence of TGF-a in keratinocytes and activated platelets (9), along with its known mitogenic effect, suggests that it may play a significant role in wound healing . In laboratory animals, TGF-a has been used successfully in treating experimentally induced wounds (10) . TGF-a and EGF are structurally homologous to fibronectins, proteoglycans, blood clotting factors IX and X and protein C (1) . These proteins play an important role in the body's response to wounding and in tissue repair.
Previous studies have focussed on the expression of TGF-a by transformed cells (2) (3) (4) . These studies failed to detect TGF-a in normal cultured fibroblasts, hematopoietic cell lines, and whole liver. However, TGF-a has been detected in ascites from patients with cirrhosis, breast, activated platelets, and rodent fetuses (reviewed in reference 2). At the completion of this manuscript, Coffey et al. (11) reported the production of TGF-a in keratinocytes .
In our studies, it was apparant that TGF-a was present on cells in the dermal infiltrates of inflammatory, hyperproliferative (psoriasis), and neoplastic skin diseases. In addition, endothelial cells from psoriatic plaques appeared to contain TGF-a. Double-labeling immunoperoxidase experiments are in progress to identify whether macrophages, Langerhans' cells, and/or activated T cells contain TGF-a. These cells are found in the dermal infiltrates of delayed type hypersensitivity reactions (12, 13) and of inflammatory and hyperproliferative skin diseases such as psoriasis and lichen planus (6) . TGF-a and possibly other factors that promote keratinocyte proliferation may play a significant role in the generation of the acanthosis seen in these conditions. Summary Transforming growth factor a (TGF-a) is a 50-amino acid peptide, previously demonstrated only in transformed cell lines and human tumors, which is structurally homologous to epidermal growth factor (EGF) . TGF-a expression in keratinocytes from normal individuals, patients with psoriasis, and patients with malignant skin diseases was investigated using an mAb raised against synthetic human TGF-a. mAb A1 .5 reacted with TGF-a, but not EGF, in a sensitive ELISA. Keratinocytes in eight nodular basal cell carcinomas, one morpheic basal cell carcinoma, and one squamous cell carcinoma demonstrated intense membranous immunoperoxidase staining with mAb Al . 5. Of even greater interest was the observation that the overlying normal epidermis, as well as the epidermis from five normal skin specimens, were stained by the mAb . Keratinocytes in plaques from 18 psoriasis patients were more intensely stained than those from normal skin. Cultured normal keratinocytes demonstrated membranous staining with mAb A1 .5 . Absorption of mAb A1 .5 with synthetic human TGF-a completely re-moved the reactivity of mAb A1 .5 with both basal cell tumors and normal epidermis .
The demonstration of TGF-a in normal keratinocytes suggests that it plays a role in normal keratinocyte growth, wound healing, and in the pathogenesis of acanthosis .
